UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

The long-term impact and value of curative therapy for HIV: a modelling analysis

Journal of the International AIDS Society, 2023-09, Vol.26 (9), p.e26170-e26170

2023

Link zum Volltext

Verfügbarkeit prüfen

The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis

Scientific reports, 2024-02, Vol.14 (1), p.2739-2739, Article 2739

2024

Link zum Volltext

Verfügbarkeit prüfen

Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis

Journal of managed care & specialty pharmacy, 2016-08, Vol.22 (8), p.939

2016

Link zum Volltext

Verfügbarkeit prüfen

Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis

Annals of internal medicine, 2023-05, Vol.176 (5), p.585

2023

Link zum Volltext

Verfügbarkeit prüfen

Population Genomic Screening for Three Common Hereditary Conditions

Annals of internal medicine, 2023-11, Vol.176 (11), p.eL230322

2023

Link zum Volltext

Verfügbarkeit prüfen

THE AUTHORS RESPOND

Journal of managed care & specialty pharmacy, 2021-08, Vol.27 (8), p.1141

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke: Current Evidence

Stroke (1970), 2014-10, Vol.45 (10), p.3032-3039

2014

Link zum Volltext

Verfügbarkeit prüfen

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

Value in health, 2019-09, Vol.22 (9), p.988-994

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States

Genetics in medicine, 2022-05, Vol.24 (5), p.1017-1026

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States

Journal of clinical lipidology, 2022-09, Vol.16 (5), p.667-675

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study

Journal of medical economics, 2019-10, Vol.22 (10), p.1006-1013

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes

Journal of managed care & specialty pharmacy, 2021-04, Vol.27 (4), p.455

2021

Link zum Volltext

Verfügbarkeit prüfen

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

CNS oncology, 2018-07, Vol.7 (3), p.CNS23

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma

Journal of managed care & specialty pharmacy, 2021-05, Vol.27 (5), p.615

2021

Link zum Volltext

Verfügbarkeit prüfen

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

Leukemia & lymphoma, 2019-06, Vol.60 (7), p.1668-1676

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States

JAMA network open, 2020-10, Vol.3 (10), p.e2022874-e2022874

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States

Journal of managed care & specialty pharmacy, 2018-01, Vol.24 (1), p.29

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

PharmacoEconomics, 2020-02, Vol.38 (2), p.171-179

2020

Link zum Volltext

Verfügbarkeit prüfen

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Journal of personalized medicine, 2016-11, Vol.6 (4), p.20

2016

Link zum Volltext

Verfügbarkeit prüfen

Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer

Journal of medical economics, 2021-01, Vol.24 (1), p.1309-1317

2021

Link zum Volltext

Verfügbarkeit prüfen

The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy

Journal of managed care & specialty pharmacy, 2020-05, Vol.26 (5), p.620

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US

Journal of medical economics, 2018-10, Vol.21 (10), p.960-967

2018

Link zum Volltext

Verfügbarkeit prüfen

Alterations in CDH15 and KIRREL3 in Patients with Mild to Severe Intellectual Disability

American journal of human genetics, 2008-12, Vol.83 (6), p.703-713

2008

Link zum Volltext

Verfügbarkeit prüfen

What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?

International journal of stroke, 2017-02, Vol.12 (2), p.137-144

2017

Link zum Volltext

Verfügbarkeit prüfen

The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care

Stroke (1970), 2012-06, Vol.43 (6), p.1617-1623

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(58)
Dissertationen
(1)

Sprache

Englisch
(59)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The long-term impact and value of curative therapy for HIV: a modelling analysis

The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis

Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis

Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis

Population Genomic Screening for Three Common Hereditary Conditions

THE AUTHORS RESPOND

Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke: Current Evidence

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States

Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study

Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer

The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy

Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US

Alterations in CDH15 and KIRREL3 in Patients with Mild to Severe Intellectual Disability

What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?

The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care

Suchergebnisse filtern